Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Video

Leslie Lauersdorf breaks down what it means to be MRD negative and how she explains MRD negativity to her patients.
As multiple myeloma moves toward being considered a chronic disease, nurses and navigators have new considerations to keep in mind when treating their patients.
Leslie Lauersdorf explains triplet versus quad regimens in relation to multiple myeloma.
Leslie Lauersdorf discusses key considerations for nurses and navigators surrounding the use of CAR T-cell therapy in multiple myeloma.
Leslie Lauersdorf provides an overview of some of the most exciting clinical developments in multiple myeloma based on data presented at ASH 2019.
Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients.
Dr Andrey Antov sees much potential for navigators when it comes to applying genetic and genomic testing to cancer care.
Dr Andrey Antov expands on how the healthcare team can work together to provide the best possible care for their patient.
Dr Andrey Antov recognizes how important the role of the navigator is in dealing with genetic and genomic testing, as the navigator often needs to help the patient gain access to the appropriate therapy, work with different stakeholders, monitor data, and more.
Dr Andrey Antov believes it's important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole.
Page 1 of 8
Results 1 - 10 of 80